SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-065598
Filing Date
2018-11-02
Accepted
2018-11-02 08:31:09
Documents
3
Period of Report
2018-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39442_18k.htm 8-K 35601
2 EX-99.1 a18-39442_1ex99d1.htm EX-99.1 99198
3 EX-99.2 a18-39442_1ex99d2.htm EX-99.2 83957
  Complete submission text file 0001104659-18-065598.txt   220103
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 181155564
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1